Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (411-420 of 655) with videos related to

Pageof 66
Sort By:
Journal of Extracellular Vesicles|April 14, 2015
Exosomal sorting of the viral oncoprotein LMP1 is restrained by TRAF2 association at signalling endosomesFrederik J Verweij, Cecilia de Heus, Stefanie Kroeze, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1992
Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancerJ H Schornagel, S van der Vegt, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2002
Dose-dense cisplatin/paclitaxel. a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancerF E de Jongh, R de Wit, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanomaA S Planting, M E van der Burg, S H Goey, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of fotemustine in advanced soft tissue sarcomas. A trial of the EORTC Soft Tissue and Bone Sarcoma GroupP Kerbrat, R Somers, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials GroupW W ten Bokkel Huinink, A M Prove, M Piccart, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 7, 2007
Pitfalls of the application of microdialysis in clinical oncology: controversial findings with docetaxelW J Loos, W C Zamboni, F K Engels, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Clinical Chemistry|November 8, 2008
Novel automated biomarker discovery work flow for urinary peptidomicsCrina I Balog, Paul J Hensbergen, Rico Derks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group StudyM Van Glabbeke, A T van Oosterom, J W Oosterhuis, et al.
Pageof 66

Showing results (411-420 of 655) with videos related to

Sort By:
Pageof 66
Journal of Extracellular Vesicles|April 14, 2015
Exosomal sorting of the viral oncoprotein LMP1 is restrained by TRAF2 association at signalling endosomesFrederik J Verweij, Cecilia de Heus, Stefanie Kroeze, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1992
Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancerJ H Schornagel, S van der Vegt, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2002
Dose-dense cisplatin/paclitaxel. a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancerF E de Jongh, R de Wit, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanomaA S Planting, M E van der Burg, S H Goey, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of fotemustine in advanced soft tissue sarcomas. A trial of the EORTC Soft Tissue and Bone Sarcoma GroupP Kerbrat, R Somers, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials GroupW W ten Bokkel Huinink, A M Prove, M Piccart, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 7, 2007
Pitfalls of the application of microdialysis in clinical oncology: controversial findings with docetaxelW J Loos, W C Zamboni, F K Engels, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Clinical Chemistry|November 8, 2008
Novel automated biomarker discovery work flow for urinary peptidomicsCrina I Balog, Paul J Hensbergen, Rico Derks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group StudyM Van Glabbeke, A T van Oosterom, J W Oosterhuis, et al.
Pageof 66